| Issuer | % of Class | Filed |
|---|---|---|
|
Quantum Biopharma Ltd.
13G/A
Amendment 8
QNTM · 74764Y205
|
9.8% |
2/3/2026
Event 2/3/2026
|
|
Quantum Biopharma Ltd.
13G/A
Amendment 7
QNTM · 74764Y205
|
27.4% |
9/4/2025
Event 6/11/2025
|
|
Quantum Biopharma Ltd.
13G/A
Amendment 6
QNTM · 74764Y205
|
21.8% |
7/18/2025
Event 7/18/2025
|
|
Quantum Biopharma Ltd.
13G/A
Amendment 5
QNTM · 74764Y205
|
19.4% |
7/10/2025
Event 7/10/2025
|
|
Quantum Biopharma Ltd.
13G/A
Amendment 4
QNTM · 74764Y205
|
19.9% |
7/10/2025
Event 7/10/2025
|
|
Quantum Biopharma Ltd.
13G/A
Amendment 3
QNTM · 74764Y205
|
19.9% |
7/10/2025
Event 7/10/2025
|
|
Quantum Biopharma Ltd.
13G/A
Amendment 1
QNTM · 74764Y205
|
19.9% |
6/30/2025
Event 6/11/2025
|
|
Quantum Biopharma Ltd.
13D/A
Amendment 3
QNTM · 74764Y205
|
17.8% |
6/23/2025
Event 6/12/2025
|
|
Quantum Biopharma Ltd.
13D/A
Amendment 2
QNTM · 74764Y205
|
17.0% |
6/23/2025
Event 6/12/2025
|
|
Quantum Biopharma Ltd.
13D/A
Amendment 1
QNTM · 74764Y205
|
14.8% |
6/16/2025
Event 6/12/2025
|
|
Quantum Biopharma Ltd.
13D
QNTM · 74764Y205
|
14.6% |
6/12/2025
Event 6/12/2025
|
|
Quantum Biopharma Ltd.
13G
QNTM · 74764Y205
|
13.2% |
6/11/2025
Event 6/11/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.